English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Mar 22, 2026

Pfizer reports phase 2 trial results for Ibrance successor in breast cancer treatment
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

AI drug discovery platforms face new challenges in attracting investors
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

Astellas ends partnership with CytomX despite positive early cancer drug data
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

Rhythm’s Imcivree fails to meet main goal in late-stage obesity trial
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

FDA issues third rejection for Aldeyra’s dry eye disease drug on March 17
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

Federal judge blocks Kennedy’s vaccine policy overhaul, citing procedural failures
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

FDA expands leucovorin use for rare disease amid scrutiny of regulatory standards
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

Study links gut microbe molecules to coronary heart disease risk

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
+ Pharmaceuticals
Patient Daily | Aug 7, 2026

Researchers develop computer model linking brain chemistry to neural activity patterns